The kk gene encodes a lymphocyte-specific protein tyrosine kinase of the nonreceptor type that is implicated in signal transduction pathways emanating from the CD4 and CD8 coreceptors. Previous studies also support a role for p56 kk in regulating T cell receptor/~ gene rearrangements and, more generally, thymocyte development. Here we report that a mutant form of p56 ~k, which is incapable of interacting with CD4 or CD8, behaves indistinguishably from associationcompetent p56 ~k with respect to its ability to affect thymocyte maturation. The effects of p56 ~k remained specific in that the closely related src-family kinase p59 ~k was incapable of substituting for p56 ~ in arresting ~ locus gene rearrangements. These data support the view that src-family kinases perform highly specialized and often nonoverlapping functions in hematopoietic cells, and that p56 kk acts independently of its association with CD4 and CD8 to regulate thymocyte development.
T
he p56 "k signaling molecule is a 509 residue src-like protein tyrosine kinase that is expressed almost exclusively in T lymphocytes (1) (2) (3) . Originally identified as the product of a gene that was activated by retroviral insertion in certain murine lymphoid cell lines (1, 4) , the kk gene is expressed in thymocytes from the time that hematopoietic progenitors first colonize the thymic anlage, and kk transcripts accumulate in all thymocyte subsets and all mature T cell populations (1, 2, (5) (6) (7) . Involvement of p56 ~k in lymphocyte signaling was suggested by the ability of mutant activated forms of this protein, those lacking a conserved COOH-terminal tyrosine phosphorylation site (Y505), to transform both fibroblasts in vitro (8, 9) and lymphoid cells in transgenic mice (10) . Moreover, p56 ~ physically associates with the CD4 and CD8 coreceptor structures on T lymphocytes (11) (12) (13) , and becomes activated when CD4 is crosslinked using anti-CD4 antibodies (14) (15) (16) . Paired cysteine residues in the NHz-terminal domain of p56 kk, and in the short intracellular segments of both CD4 and CD8, are required for this association (17, 18) . In one study, transfection of a lysozyme-specific T cell hybridoma that requires CD4 for antigen recognition with constructs encoding a CD4 molecule lacking these cysteine residues resulted in loss of CD4 signaling capacity (19) . These observations, in aggregate, have given weight to the hypothesis that antigen recognition by T cells is potentiated when the CD4 or CD8 coreceptor structure becomes associated with the antigen receptor complex, thereby approximating the p56 ~k kinase to the CD3 signaling machinery (20) .
Whereas p56 ~k almost certainly serves a crucial function in relaying signals from coreceptor molecules, there are many circumstances in which the signaling capacity of p56 ~ appears unrelated to CD4 and CD8 expression. For example, p56 ~k is expressed at high levels in NK cells (2, 6, 21, 22) , where CD4 and CD8 do not participate in antigen recognition. Moreover, lck transcripts accumulate to the greatest extent in thymocytes, including CD4-8-thymocytes (2, (5) (6) (7) . In one set of experiments, expression of activated p56 ~k (bearing a phenylalanine residue at position 505) in an insnlinreactive T cell line yielded cells with a much increased sensitivity to antigen, despite the fact that these cells failed to express CD4 or CD8 (23) . A more recent study demonstrated that loss of p56 ~k expression in the CD4-8-transformed human T cell line Jurkat resulted in a nearly complete block in TCR-mediated signaling which could be reconstituted by expression of wild-type p56 ~k (24) . These results suggest that p56 kk may contribute to T cell signaling pathways other than those that emanate from the CD4-and CD8 receptors. Consistent with this view, p56 kk has been shown to associate with the/~ chain of the IL-2 receptor, and becomes activated after IL-2 treatment of normal T cells (25, 26) .
Previous studies demonstrate that thymocyte development is exquisitely sensitive to levels of p56 ~ activity. Mice bearing a targeted disruption of the kk gene (27) , or expressing high levels of a dominant-negative form of p56 ~k (28) , manifest a severe block in thymocyte maturation resulting in a 20-50-fold reduction in thymocyte number, primarily as a result of decreased generation of CD4+8 + cells from CD4-8-precursors. Augmented expression of p56 ~k in transgenic mice under the control of its own promoter provided more insight into this phenomenon. Mice expressing very high levels of p56 ~k, and especially those expressing the mutant (F505) activated form, rapidly develop thymic tumors, supporting the view that p56 ~i activity promotes mitogenesis (10) . More importantly, even modest overexpression of p56 ~ yields thymocytes in which TCR gene rearrangement no longer follows the normal developmental sequence. In these animals, joining of VB gene segments to D~ gene segments fails to occur, even though Voe to Joe rearrangement, ordinarily a later event, proceeds normally (29, 30) . These observations support a model in which p56 ~k serves to regulate rearrangement at the 3 locus, perhaps by perceiving the correct expression of a CB-containing gene product (30) .
In principle, the signaling disturbances that occur in mice expressing high levels of p56 ~k could reflect delivery of signals from the CD4/CD8 coreceptors, from the IL-2 receptor, or from some other receptor structure. To elucidate the nature of this signaling pathway, we have generated transgenie mice in which the same construct previously employed to express high levels of p56 ~k in thymocytes was modified to permit expression of a mutant form of p56 ~k that cannot interact with CD4 or CD8, and have examined the effects of simultaneous overexpression of wild-type CD4 in both animal systems. We have also expressed an activated version of a closely related protein tyrosine kinase, p59 ~'k, in thymocytes using the same thymocyte-specific promoter. Examination of these animals reveals that interaction with CD4 is not required to permit elaboration of an/ck-overexpression phenotype, and indeed CD4 actually appears to "sequester" p56 ~k and render it less potent. Our results provide strong support for the proposition that p56 ~k regulates thymocyte development independently of its ability to interact with CD4 and CD8, and does so uniquely, in that closely related kinases, expressed in activated forms and at high levels, cannot mimic its effects.
Materials and Methods
Transgene Expression Vector and Transgenic Mouse Production. The pkkFS05 expression vector has been described dsewhere (10, 29) . Site-directed mutagenesis (31) was used to convert cysteine codons 20 and 23 to ahnine codons (codon 20 changed from TGT to GCC and codon 23 changed from TGC to GCG). The mutagenesis was carried out on a kk eDNA. After confirming the presence of the mutation and the absence of other changes by DNA sequencing (32), a 125-bp StuI/BgllI fragment containing the mutation was isolated and substituted for the corresponding wild-type fragment in pkkF505 (29) . An 11.2-kb XhoI/NotI fragment was then purified on low malting point agarose gels and injected into C57BL/6J x DBA/2 F2 zygotes to generate transgenic mice.
The p1017 vector has been described (33, 34) , as has a human hck eDNA in which site-directed mutagenesis was employed to convert tyrosine codon 501 to a phenylalanine codon (35) . The hckFS01 eDNA was purified as an EcolLl fragment, made bluntended using T4 DNA polymerase, and ligated into p1017 at the BamHI site which was also filled-in using T4 DNA polymerase. A 7-kb NotI fragment was excised and used to generate transgenic mice as above.
Transgene-bearing animals were identified by hybridization to a probe for the human growth hormone 3' region (10, 29) . Tramgenie lines were created by crossing founders to C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME).
Flow Cytoraetry. Lymphocyte suspensions were generated by compression of lymphoid organs between ground glass slides. RBC were lysed using NH4C1 lysis as previously described (29) Immunoblot Analysis. Whole cell lysates were generated by solubilizing thymocytes in TNT buffer (150 mM NaC1, 50 mM Tris-C1 [pH, 8], 1% Triton X-100, I mM NaVO4, 1 mM PMSF) for 20 min at 4~ Insoluble material was removed by centrifuging at 12,000 g for 5 rain at 4~ Lysates were then boiled in SDS sample buffer, resolved on 10% (p56 ~) or 12% (p59 ~k) SDS-PAGE, and transferred to nitrocellulose. For p56 ~ and p59 h' detection, filters were blocked in 5% milk, 0.1% Tween 20. Rabbit polyclonal antisera specific for p56 ~ (195.7; 38) or p59 *' (6168. 2; 35) were used at a concentration of 1:5,000 in 1% milk, 0.1% Tween 20. After a 2-h incubation at room temperature, the filters were rinsed in 1% milk, 0.1% Tween 20, and developed using a donkey anti-rabbit secondary antibody and the Enhanced Chemiluminesence detection system (Amersham Corp., Arlington Heights, IL).
Imraunoprecipitations and In Vitro Kinase Assay. Immunoprecipitations of kinases were performed using the same antisera described above at a 1:200 dilution from 10-100/~g of total thymocyte protein. Anti-CD4 immunoFrecipitates were performed using the mAb GK1.5 plus a rabbit anti-rat IgG secondary antibody. Immune complexes were collected using Pansorbin (Calbiochem-Novabiochem, La JoUa, CA). Pellets were washed five times in TNT and two times in high salt TNT (1 M NaC1), and resuspended in kinase buffer (20 mM Tris-C1 [pH, 7.5], 10 mM MnCh, 1 mM NazVO4, 0.1% Triton X-100, plus 2 #1 per reaction of qr-[32P]ATP (3,000 Ci/mmol). These reactions were allowed to proceed for 10 rain at room temperature, and were stopped by addition of SDS sample buffer and by boiling for 3 rain before resolution on SDS-PAGE. Gels were dried and exposed to X-ray film. 32p incorporation into protein bands was determined on a Phosphorlmager | (Molecular Dynamics, Sunnyvale, CA).
Quantitation of raRNA Levels by Northern and Slot Blots. KNA was prepared according to the method of Chomczynski and Sacchi (39) and resolved on 1% agarose formaldehyde gels (40) or examined using a slot blotting apparatus (Schleicher & SchueU, Inc., I~ene, NH). Blots were probed with 32p-labeled probes generated from human growth hormone sequences, from kk or hck eDNA, or from a mouse EF-I~ cDNA as described (40) . Quantitation was performed using scanning densitometry (10, 29) .
Detection of/9 Chain Rearrangements by PCR and Northern
Blot. The synthetic oligonucleotides, PCR amplification, gel transfer, probes, and blot hybridization conditions were performed as described previously (30) . Northern blots were prepared as described above, but were probed with 32p-labded C/~ or Cc~ probes as described (30) .
Results

Expression of a CD4 /CD8 Association-Defecti~ kkFS05 Transgene.
To investigate the possibility that p56 ~k might act independently of CD4 and CD8 in blocking thymocyte maturation, we constructed a transgene that was identical to the kkFS05 transgene employed previously (10, 29; Fig. 1 A), but which also had alanine codons substituted for cysteine codons 20 and 23 ( Fig. 1 B) . Substitution of a phenylalanine codon for tyrosine at position 505 yields an "activated" version of p56 ~ that exhibits a 3-7-fold greater potency than does its wild-type counterpart (10, 29) . Previous work has demonstrated that the alanine substitutions at positions 20 and 23 eliminate the ability of p56 ~k to couple to CD4 and CD8 (17 and see below). Hence the kkFSO5A20,23 transgene product should be activated, by virtue of the F505 mutation, but unable to interact with CD4 or CD8, because of the A20/A23 substitutions. This transgene should therefore provide information regarding CD4/CD8-dependent and -independent kkF505 effects.
In all, twelve founder animals and six mouse lines were analyzed for transgene expression and thymocyte cell surface phenotype (Table 1) . Transgene expression was limited to the thymus and mRNA level were proportional to the number of copies integrated into the genome (data not shown), as was observed with the previous kkF505 construct (10, 29) .
Mice that expressed the kkFSO5A20,23 transgene at roughly twofold over endogenous kk mRNA levels developed thymic tumors (Table 1) with approximately the same kinetics as /ckF505 animals (10). It is interesting that progeny of the 7121 and 7148 founder animals developed tumors sporadically ( Table 1 ), suggesting that their expression levels lie near the threshold for tumor development (10) . All tumors were phenotypically immature as judged by CD3, CD4, and CD8 staining ( Fig. 2 ) and were indistinguishable from tumors produced in kkFS05 mice (10) . We conclude from this that transforming potential of p56 ~k is independent of its ability to associate with CD4 and CD8.
In kkF505A20,23 mice that did not develop tumors, a defect in thymocyte maturation was observed that reflected an inability to produce CD3-bearing CD4*8 -and CD4-8 + (single positive) cells (Fig. 3 ) although total thymocyte numbers were unchanged (data not shown). Instead, increased percentages of CD4+8 +, CD4-8-, and CD8+/CD3 -cells (believed to represent precursors to CD4+8 + cells) were observed. Construction of a dose-response curve plotting transgene expression versus the number of CD3 + cells demonstrated that the kkFS05 and kkFSOSA20,23 transgenes exhibit identical characteristics (Fig. 4) . Peripheral T cell numbers were also reduced in kkF505A20,23 mice, again in a manner that was indistinguishable from kkF505 animals ( Table 1 and data not shown). The inability to generate CD3 + cells in kkF505 mice results primarily from a failure to rearrange V~ TCR gene segments, such that thymocytes from these animals contain 1.0-kb ~ locus transcripts that result from D/~-JB joining, but lack mature 1.3-kb products that ordinarily reflect V/3-D/3 rearrangement (29, 30) . Fig. 5 demonstrates that this defect also characterizes thymocytes from kkFSO5A20,23 mice. Thus mature 1.3-kb B chain transcripts are not observed in developing thymocytes from kk transgenic animals, but the 1.0-kb D~-J~ mRNA is readily detected (Fig. 5 A) . Quantitation of specific V~ to DB-JB rearrangements by PCR amplification of thymocyte DNA confirms a reduction in joining events comparable to that seen in kkF505 mice (Fig.   5 B) . DB to J~/joining events, however, were detected at levels comparable to those in normal thymocytes (Fig. 5 B) . Fig.  5 A also shows that full-length o~ chain mRNA is present at normal levels in thymocytes from both types of transgenic mice. We conclude that a kk transgene product which was presumably unable to interact with either CD4 or CD8 produced the same developmental abnormalities, apparently by a similar mechanism, as a transgene product which could physically couple to these coreceptors.
The IckF505A20, 23 Transgene Product Does Not Immunoprecipitate with CD4. One possible explanation for our observations might be that p56 ~kFs~176 can in fact interact with the CD4 and CD8 coreceptors under certain circum- stances. For example, our previous experiments, and those of others, defining the region of p56 ~k responsible for coreceptor binding were performed under nonphysiological conditions in fibroblast cell lines (17, 18) . To address the extent of association of p56 ~Fs~176 with CD4 in lymphoid cells, we performed immunoprecipitation experiments using thymocyte extracts from normal, kkFS05, and kkFSO5A20,23
mice. Anti-p56 ~k immunoprecipitates showed elevated kinase activity in both kkF505 and kkF505A20,23 extracts, consistent with overexpression of the transgenes and the enhanced activity associated with the F505 mutation (Fig. 6) . However, in anti-CD4 immunoprecipitates elevated kinase activity was observed only in the/ckFS05 lysates. The kkFSOSA20,23
extracts contained CD4-associated kinase activity at about the levels seen in normal animals (Fig. 6 ). This suggested that only endogenous wild-type p56 ~k was coupling with CD4 in/ckFS05A20,23 lysates in this in vitro assay.
Rescue of lckF505 Transgene Effects by Expression of a CD4 ~ansgen~ Additional in vivo experiments permitted a much
more persuasive test of the interaction of p56 ~kFs~176 with CD4 and provided further evidence of the coreceptorindependent nature of the kk transgene effects. Previously we reported the generation of lines of transgenic mice that express high levels of mouse CD4 under the control of the /ck proximal promoter (41) . If overexpression of p56 ~k interferes with thymocyte development through overzealous delivery of a coreceptor-derived signal, we reasoned that simultaneous overexpression of CD4 and kk might yield additive effects. We therefore crossed kkF505 transgenic mice with /ck-CD4 mice (line 727), the thymocytes of which all express very high levels of CD4 (about 15-fold over normal CD4 levels seen in CD4 + 8 + cells). The/ck-CD4 transgenic mice normally exhibit no defects in TCR gene rearrangements (data not shown), although the level of CD3 expression in immature CDY ~ cells is increased somewhat (41) .
Comparison of the number of CD3 + cells in progeny from this cross revealed a remarkable recovery of CD3 + cells in thymuses from animals carrying both transgenes, as compared with thymuses from animals transgenic for kkF505 alone (Fig. 7) . In three kkF505 lines tested, coexpression of the CD4 transgene resulted in recovery of substantial numbers of CD3 + cells. Hence, it appeared that excess CD4 mitigated, to some extent, the effects of the kkF505 transgene, perhaps by binding and sequestering the excess p56 ~k. However, it was also possible that signals derived from the overexpressed CD4 product, though essentially undetectable themselves, actually acted independently of p56 ~k to antagonize the effects of the kinase. This explanation could be excluded by examining the maturation of thymocytes from the kkF505A20,23 mice that also expressed high levels of CD4. If the IckF505A20,23 transgene product was behaving as expected (i.e., not associating with CD4), there should be no recovery of CD3 + cells despite the presence of excess CD4, since sequestration should not occur. ulocytes (6, 43) . We have previously demonstrated that substitution of phenylalanine for tyrosine at position 501 yields an especially potent transforming gene when tested in NIH 3T3 cell transfection assays (35) . A hck cDNA bearing the appropriate mutation was inserted into the p1017 vector ( Fig.   1 C) which comprises a 3.2-kb kk proximal promoter fragment linked to the human growth hormone (hGH) gene which provides intronic structure, a polyadenylation signal, and a unique Y-untranslated region (33, 34) . With this vector system, transcript levels of the hck transgene could be directly compared with those observed with the/ck transgenes since each incorporates the same 3' untranslated region.
Results obtained through examination of eight independent founder animals and two lines of hckF501 animals are summarized in Table 2 . Expression of the hckF501 transgene failed to produce any tumors or phenotypic abnormalities in developing thymocytes in spite of the fact that transgene mKNA expression levels were, in at least one case, as high as those observed in kkF505 tumor-bearing lines (Table 2 ). There were also no discernible abnormalities in peripheral T cells (Table 2 and data not shown). Flow cytometric anal-),sis revealed patterns of CD4, CDS, and CD3 staining that were indistinguishable from control animals for both thymocytes and mature peripheral T cells (data not shown) in spite of the fact that the hck protein, not normally present in thymocytes, was readily detectable in extracts from hckF501 thymocytes (Fig. 9) . We conclude that simple augmentation of the levels of a src-family protein tyrosine kinase in developing thymocytes is not sufficient to provoke either tumorigenesis or developmental perturbations. Hence the effects observed with the kk transgenes reflect some unique activity of p56 ~k that is independent of its ability to interact with the CD4 and CD8 coreceptors.
transgenic (kkFS05A20,23 x CD4) mice. The failure to rescue CD3 + cells in kkF505A20,23 mice with the kk-CD4 transgene demonstrates that pSC ~Fs~176 fails to associate with CD4 in vivo (as expected), and that the attenuation of the effects of the kkF505 transgene in mice simultaneously overexpressing CD4 is due to the interaction of p56 kk with CD4, which in this case suppresses, rather than stimulates, a kinase-mediated signaling process.
Specificity of kkF505 Induced Abnormalities. Thymocytes contain numerous protein tyrosine kinases besides p56 uk (2, 6, 42). Since the developmental perturbations induced by kk
overexpression occurred independently of its association with the CD4/CD8 coreceptors, it was possible that these abnormalities might result from a nonspecific effect of augmented protein tyrosine kinase activity. To investigate this hypothesis, we generated constructs in which a closely related srcfamily kinase, p59 h'k, in an activated form lacking the regulatory COOH-terminal tyrosine (hckF501), was expressed under the control of the same kk proximal promoter element. The hck gene product is not normally found in thymocytes, but is present in cells of the myeloid lineage, especially gran- 249 Levin et al.
Discussion
p56~k: A Unique Regulator of ThTmocyte Maturation. The experiments reported above were initiated in an attempt to define the mechanism whereby expression of high levels of p56 ~k perturbs the normal thymocyte maturation sequence. Previous studies permitted us to construct a dose-response curve for the effects of augmented p5C k activity, and revealed that even very modest augmentation of the level of wild-type p56 ~k protein, expressed under the control of its own transcriptional regulatory elements, resulted in very substantial developmental abnormalities (29) . Subsequent investigation revealed that the most prominent feature of this maturational arrest, the inability to generate CD3 § thyrnocytes, resulted from a single molecular defect: the failure to catalyze VB-Dfl joining and hence the inability to produce a functional TCR fl chain (30) . The exquisitely specific nature of this abnormality suggested that augmentation of p56 ~k activity impinged on a normal regulatory process involved in controlling TCR gene rearrangement. However, in light of the fundamental regulatory roles of protein tyrosine kinases generally, it was possible that the developmental block induced by overexpression of p56 ~ might be non- specific, the result of hyperstimulation of a regulatory mechanism that need not, under normal circumstances, involve p56 ~k itself at all. Whereas we cannot exclude this argument completely, the results reported here, coupled with other studies, serve to focus attention on p56 ~k as a unique regulator of early thymocyte maturation. First, p56 uk is ordinarily expressed at highest levels in immature thymocytes (2, 5-7). This contrasts with other nonreceptor protein tyrosine kinases, notably p59f~ T, which are expressed at highest levels in mature T lineage cells (33). Second, although thymocytes are extraordinarily sensitive to the presence of augmented levels of p56 ~, simple overexpression of other nonreceptor protein tyrosine kinases does not appreciably alter early thymocyte maturation. For example, overexpression of p59f~ under the control of the proximal kk promoter yields animals with T cells that respond inordinately vigorously to stimulation of the TCK, but the thymocytes from these animals mature normall), (33) . In the present study, we used the same promoter element to express p59 ~k, a myeloid cell-specific protein tyrosine kinase ordinarily expressed at highest levels in gran- Figure 6 . p56kkrs~ 23 failed to associate with CD4 in thymocyte extracts. Detergent extracts were prepared (see Materials and Methods) from thymocytes isolated from a normal mouse (N/-~, from an animal of the kkF505 3073 line (29) , or from an animal of the kkF505A20,23 7120 line. Immunopreeipitations were performed using either an anti-p56 ~k antiserum or an anti-CD4 mAb. In vitro kinase activity was assayed using these immune complexes, and the products were subsequently resolved on 10% SDS-PAGE. Autophosphorylation of p56 kk and phosphorylation of enolase were measured by quantitation of 52p incorporation using a Molecular Dynamics Phosphotimager. These values (bottom) are expressed relative to those obtained using immunopreeipitates from the normal thymocytes. Figure 5 . Thymocytes from kkFS05A20,23 mice were deficient in Vfl rearrangements and mature TCR-fl transcripts but produced normal levels of TCR-ot transcripts. (.4) Total thymocyte RNA was prepared from a normal mouse (NLC), from two lines of khFS05 mice, and from four lines of kkF505A20,23 animals. 10 #g of each RNA sample was separated on a 1% agarose/formaldebyde gel, blotted onto a nylon filter, and probed for Cfl-(top) or Ca-(bottom) containing transcripts. Two Cfl transcripts were observed: an immature 1.0-kb form which represents transcription initiating adjacent to rearranged Dfl elements, and the mature 1.3-kb transcript originating from VflD~I~ rearranged DNA. Only the immature transcript was present in all transgenic animals except for the kkF505A20,23 4972 line which expressed very little of the transgene mRNA and produced normal numbers of CD3 § cells (see Table 1 ). A single 1.6-kb mature Cc~ transcript was observed and this was present at roughly the same levels in all thymocyte RNA samples examined. (/3) Vfl8 (top) and Dfl2 (bottom) rearrangements to J~2 segments were amplified by PCR using thymocyte DNA from the indicated normal or transgenic animals. Specific rearrangements in tramgenic thymocytes are reduced in abundance by >80% as compared with control thymocytes.
ulocytes. In fibroblast transformation assays, p59 hckvs~ exhibits 100-fold more transforming activity than does p56 ~kFs~ (35) . Yet, thymocytes tolerate high level expression of this potent transforming gene w i t h impunity (Table 2) . Hence p56 k~ acts uniquely in blocking thymocyte maturation.
It should also be noted that mice lacking a functional Ick using an Ick transgene that encodes a catalytically inactive form of pSC ~. As the level of this protein increases, thymocyte production becomes progressively attenuated (28) . Thus, the catalytically inactive form of p 5 C k acts as a dominantnegative inhibitor of p56 ~k function. Intriguingly, the thymocytes from animals bearing high levels of catalytically in- Figure 9 . Expression of p59 I'~ in thymocyte extracts from hckF501 transgenic mice. Cell extracts were prepared from normal thymocytes (NLC), from hckF501-expressing thymocytes (HYF 2173), or from NIH 3T3 cells transfected with an/~kP501 cDNA under transcriptional control of the metallothioein I promoter (MT 2.1) (53). 40 #g of total protein was resolved on 12% SDS-PAGE, transferred to nitrocellulose, and detected with an hck-specific antiserum. (-~) Position of p59 h'k. There is also a slightly smaller unidentified crossreacting band in aU lanes. active p56 ~k support normal levels of V~ gene rearrangement (28) . These observations have prompted us to suggest that p56 ~ normally promotes thymocyte maturation by sensing the correct synthesis of a T C K /~ chain, and thereafter by directing that further rearrangements at the ~ locus cease and that cell replication proceed (28, 30) . When p5C k is overexpressed in an active form, thymocytes are generated that appear to have received these signals inappropriately. In these cells, VB rearrangement is attenuated before satisfactory assembly of a functionally rearranged T C R ~ gene is complete. Although the specific targets of p56 ~k action remain undefined, it is apparent that the/ck-encoded kinase acts relatively uniquely to deliver this signal, and that the signaling process requires protein tryosine kinase activity, since catalytically inactive p56 ~ does not promote the same effects (28) . Al- though the general function of src-family kinases remains mysterious, it is believed that these molecules assist in relaying signals from the cell surface to the cell interior. This conclusion derives in large part from the study of p56 ~k and p59fr" in lymphocytes. The hematopoietic isoform of p59~ (p59fr,T) interacts physically and functionally with the CD3 complex on T lymphocytes (33, (44) (45) (46) , and loss of p59fv' blocks antigen-induced signal transduction to a large extent, especially in mature thymocytes (45, 46) . In contrast, p56 ~k appears to interact with at least three, and perhaps more receptor structures. A unique motif in its NH2-terminal domain confers upon it the ability to interact with the CD4 and CD8 coreceptors (17, 18) , while its kinase domain can associate physically and functionally with the IL-2 receptor ~/chain (47) . A recent report also documents the presence of p56 ~t in immunoprecipitates formed using antisera to a variety of T cell surface proteins linked via a phosphatidylinositol-glycan moiety to the cell membrane (48) . In principle, any or all of these receptor structures might stimulate p56 ~t to suppress thymocyte development. However, our data make plain that these signals do not arise from CD4 or CD8. In fact, augmented expression of CD4 appears to sequester p56 ~k and prevent it from blocking VB gene rearrangement (Fig. 7) . Thus animals of the 2954 kkFS05 line, expressing approximately 12 pg/#g of transgene-derived transcript, behave more like those of the 3073 line, expressing 6 pg/lzg of transgene mRNA (29) , when a 15-fold excess of CD4 is present (Fig. 7 and data not shown). The inability of excess CD4 to rescue CD3 expression in thymocytes bearing an kkF505A20,23 transgene demonstrates the importance of the p56 ~k cysteine motif in permitting CD4 to ameliorate the untoward effects of kinase overexpression. We have previously noted that expression of augmented levels of CD4 appeared to sequester endogenous p56 ~k and block signaling in an antigen-specific thymocyte selection system, and that this ability depended upon the presence of the cytoplasmic tail of CD4 which contains a p56~k-binding motif (41, 49) . Similarly, Haughn et al. have proposed that sequestration of p56 ~k by CD4 can explain the nonresponsiveness induced in a CD4-OVA-specific T cell line after expression of retroviraUy encoded wild-type CD4 protein (50) . Thus although CD4-mediated signaling in antigen-specific T cell lines may require interaction with p56 ~k (19) , potentiation of p56 ~-mediated responses is not dependent solely on CD4.
Nature of the Signaling Structure that Activates p56t~k
We can similarly conclude that the IL-2 receptor, though capable of binding p56 ~k, probably does not activate its ability to arrest thymocyte development. First, p59fw can be shown to bind to the IL-2 receptor ~ chain and to be activated by IL-2 (51) , and yet overexpression of p59fw does not influence early thymocyte development (33) . Second, mice lacking IL-2 as a result of a targeted gene disruption display no abnormalities in thymocyte maturation. In light of these observations, and since p56 ~ expression is both required for normal thymocyte development, and incompatible with normal thymocyte development if it exceeds routine levels to any great extent, we conclude that p56 ~k must ordinarily act through interactions with a receptor structure that is neither CD4, CDS, nor the IL-2 receptor ~ chain. In this context, it is important to note that p56 ~k appears to promote signaling from the TCK itself in both a murine system, where overexpression of p56 ~k improves antigen-specific responses in the complete absence of coreceptor expression (23) , and in a human T cell tumor line, where loss of p56 ~k expression blocks TCK signaling (24) . These observations are compatible with the view that p56 ~ functionally couples directly to the TCR-CD3 complex in mature T cells and thus could also do so during thymocyte development to sense the correct assembly of some portion of the TCR complex that depends upon ~ chain expression, but does not require either CD4 or CD8.
Selective Functions of m-Family Protein Tyrosine Kinases.
The src-family protein tyrosine kinases are expressed in specialized forms in hematopoietic cells (2, 52) . Indeed, 5/8 of these kinases (blk,fgr, hck, Ick, and lyn) are expressed only in blood cells, and thefyn gene encodes two distinct proteins, one of which is hematopoietic cell specific (52) . The effects of p56 ~k on thymocyte development illustrate an emerging general principle: these nonreceptor kinases, even when expressed simultaneously in single cells, perform highly specialized signaling functions. Thus loss offyn gene expression yields thymocytes that mature satisfactorily but fail to transmit normal TCK-derived activation signals (45, 46) . In contrast, loss of /ck gene expression blocks normal thymocyte development almost completely (27) . Our studies of the effects of p56 ~k overexpression add a further dimension to this analysis. Other src-family kinases, though similar in overall configuration and in their ability to phosphorylate substrates in vitro, simply cannot deliver a signal that suppresses B chain gene rearrangement. Definition of the structural features of p56 ~t that endow it with its functional attributes should provide clues for the identification of molecules, both receptors and effectors, that regulate the development of T lymphocytes.
